Table 2.
Multivariable Cox regression analysis in 398 patients admitted with SARS-CoV-2 in a West London population, during March 1–April 23, 2020
| Variable | Hazard ratio | Lower 95% CI | Upper 95% CI | p value |
|---|---|---|---|---|
| Age | 1.05 | 1.03 | 1.07 | < 0.005 |
| Sex (F) | 0.6 | 0.36 | 1 | 0.05 |
| Cardiac failure | 2.92 | 1.52 | 5.62 | < 0.005 |
| Cerebrovascular event | 2.36 | 1.28 | 4.36 | 0.01 |
| Chronic kidney disease | 2.32 | 1.31 | 4.1 | < 0.005 |
| Chronic liver disease | 3.52 | 1.2 | 10.35 | 0.02 |
| Chronic respiratory disease | 0.9 | 0.53 | 1.53 | 0.7 |
| Diabetes | 1.41 | 0.86 | 2.3 | 0.17 |
| Hypertension | 1.02 | 0.64 | 1.63 | 0.93 |
| Ischaemic heart disease | 2.09 | 1.29 | 3.4 | < 0.005 |
| Obesity | 2.74 | 0.97 | 7.7 | 0.06 |
| NOD | 1.01 | 0.97 | 1.05 | 0.65 |
| Abdominal pain | 0.29 | 0.08 | 1.02 | 0.05 |
| Collapse | 4.21 | 2.4 | 7.41 | < 0.005 |
| Confusion | 6.03 | 3.5 | 10.41 | < 0.005 |
| Cough | 1.88 | 1.1 | 3.2 | 0.02 |
| Diarrhoea/vomiting | 1.32 | 0.68 | 2.54 | 0.41 |
| Dyspnoea | 3.49 | 1.93 | 6.32 | < 0.005 |
| Fever | 1.88 | 1.13 | 3.13 | 0.02 |
| Myalgia | 1.43 | 0.69 | 2.94 | 0.33 |
| Olfactory change | 0.87 | 0.31 | 2.47 | 0.79 |
NOD Number of days of symptoms prior to hospital admission